Merck Manual

Please confirm that you are a health care professional

honeypot link

Treatment of Anemia

By

Evan M. Braunstein

, MD, PhD, Johns Hopkins University School of Medicine

Last full review/revision Sep 2020| Content last modified Sep 2020
Click here for Patient Education

If identified, the cause of the anemia is treated. When the hemoglobin (Hb) falls dangerously low (eg, < 7 g/dL [< 70 g/L] for patients without cardiopulmonary insufficiency or higher for patients with it), red blood cell (RBC) transfusion temporarily increases oxygen-carrying capacity. RBC transfusion should be reserved for patients

  • With or at high risk of cardiopulmonary symptoms

  • With active, uncontrollable blood loss

  • With some form of hypoxic or ischemic end-organ failure (eg, neurologic ischemic symptoms, angina, tachycardia in patients with underlying heart failure or severe chronic obstructive pulmonary disease)

Transfusion procedures and blood components are discussed elsewhere, as is the evaluation of anemia.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

OTHER TOPICS IN THIS CHAPTER

Professionals also read

Test your knowledge

Overview of Thrombotic Disorders
Thrombotic disorders can be caused by genetic defects, which increase the risk of venous thromboembolism, or acquired defects, which increase the risk of arterial and venous thrombosis. Of the acquired causes, which of the following is most likely to increase a patient’s risk of venous thrombosis?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
 

Also of Interest

 
TOP